Trivitron Healthcare, led by GSK Velu, records profitability once more following private equity departure
After a challenging couple of years, Trivitron Healthcare, a leading medical devices and consumables supplier based in Chennai, has made a significant comeback. In FY2025, the company reported a profit after tax (PAT) of INR 2.9 crore, a stark contrast to the loss of INR 10.8 crore in FY2024.
The company's financial turnaround is a result of its own efforts, as no specific external factors were mentioned in the text. Operational restructuring and promoter-led funding have been key strategies in Trivitron Healthcare's financial recovery.
The operational restructuring has played a crucial role in improving the company's financial health. Operating income increased from INR 440.6 crore in FY2024 to INR 489.8 crore in FY2025. Operating margins improved to 6.1% supported by cost-optimisation measures and a better product mix.
The company's total outside liabilities to tangible net worth ratio decreased from 5.4 times in FY2024 to 4.4 times in FY2025, indicating reduced leverage. The adjusted debt to OPBDIT (Operating Profit Before Depreciation, Interest, Taxes and Amortisation) ratio improved significantly from 6.4 to 3.7 times, reflecting better debt servicing capacity. Interest coverage also improved from 1.4 to 1.7 times.
These financial metrics suggest that post-exit of the private equity investors, Trivitron Healthcare has strengthened its operating profitability, reduced losses, improved capital structure, and enhanced its ability to cover interest expenses, indicating a healthier financial position.
If you're interested in staying updated on such developments, the article offers access to premium content. Already existing members can log in to access the content, and the cost or terms of becoming a Premium member are not specified in the text. The nature or topic of the premium content is also not disclosed.
[1] Source: Company's Annual Report for FY2025
- Trivitron Healthcare's significant improvements in financial health, as evident in their increased operating income and reduced leverage, can be attributed to their strategic operational restructuring and promoter-led funding, which falls under the broader context of the finance and industry sectors.
- In the science and medical-conditions realm, understanding the financial strategies that contribute to the turnaround of companies like Trivitron Healthcare can provide valuable insights, as such learnings could potentially be applied to the development and distribution of innovative medical devices and treatments.
